Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Reports (Hoboken, N.J.)|August 9, 2024
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid LeukemiaChiara Ronchini, Federica Gigli, Martina Fontanini, et al.
International Journal of Cancer|June 13, 2022
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomesElisabetta Todisco, Federica Gigli, Chiara Ronchini, et al.
Leukemia & Lymphoma|June 29, 2010
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patientsPaola Bertazzoni, Cristina Rabascio, Federica Gigli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2015
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)Christoph Mamot, Dirk Klingbiel, Felicitas Hitz, et al.
Leukemia Research|February 8, 2016
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"Alfredo Molteni, Marta Riva, Lorenza Borin, et al.
The Oncologist|November 28, 2024
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort studyCarmine Valenza, Eleonora Nicolò, Marta Mongillo, et al.
Cancers|January 23, 2024
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica LombardaGiuseppe Rossi, Erika Borlenghi, Patrizia Zappasodi, et al.
Acta Haematologica|September 18, 2024
Bosutinib Treatment of Chronic Myeloid Leukemia in LombardyAlessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, et al.
Hematological Oncology|January 13, 2026
NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON CohortCalogero Vetro, Irene Azzali, Elisabetta Petracci, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 10, 2012
Multicenter experience using total lymphoid irradiation and antithymocyte globulin as conditioning for allografting in hematological malignanciesGiuseppe Messina, Luisa Giaccone, Moreno Festuccia, et al.
Pageof 3